153 related articles for article (PubMed ID: 31729755)
1. Historical and new insights into pathogenesis of type 1 diabetes.
Wong FS; Tree TI
Clin Exp Immunol; 2019 Dec; 198(3):292-293. PubMed ID: 31729755
[TBL] [Abstract][Full Text] [Related]
2. Historical and new insights into pathogenesis of type 1 diabetes (2).
Wong FS; Tree TI
Clin Exp Immunol; 2021 May; 204(2):165-166. PubMed ID: 33890285
[TBL] [Abstract][Full Text] [Related]
3. Neither B lymphocytes nor antibodies directed against self antigens of the islets of Langerhans are required for development of virus-induced autoimmune diabetes.
Holz A; Dyrberg T; Hagopian W; Homann D; von Herrath M; Oldstone MB
J Immunol; 2000 Nov; 165(10):5945-53. PubMed ID: 11067957
[TBL] [Abstract][Full Text] [Related]
4. Visualizing the role of Cbl-b in control of islet-reactive CD4 T cells and susceptibility to type 1 diabetes.
Hoyne GF; Flening E; Yabas M; Teh C; Altin JA; Randall K; Thien CB; Langdon WY; Goodnow CC
J Immunol; 2011 Feb; 186(4):2024-32. PubMed ID: 21248249
[TBL] [Abstract][Full Text] [Related]
5. The potential of multimer technologies in type 1 diabetes prediction strategies.
Fierabracci A
Diabetes Metab Res Rev; 2011 Mar; 27(3):216-29. PubMed ID: 21309048
[TBL] [Abstract][Full Text] [Related]
6. Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune Diabetes.
Michels AW; Landry LG; McDaniel KA; Yu L; Campbell-Thompson M; Kwok WW; Jones KL; Gottlieb PA; Kappler JW; Tang Q; Roep BO; Atkinson MA; Mathews CE; Nakayama M
Diabetes; 2017 Mar; 66(3):722-734. PubMed ID: 27920090
[TBL] [Abstract][Full Text] [Related]
7. The role of B lymphocytes as key antigen-presenting cells in the development of T cell-mediated autoimmune type 1 diabetes.
Serreze DV; Silveira PA
Curr Dir Autoimmun; 2003; 6():212-27. PubMed ID: 12408054
[No Abstract] [Full Text] [Related]
8. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.
Lejon K; Fathman CG
J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102
[TBL] [Abstract][Full Text] [Related]
9. Identifying New Hybrid Insulin Peptides (HIPs) in Type 1 Diabetes.
Mannering SI; Rubin AF; Wang R; Bhattacharjee P
Front Immunol; 2021; 12():667870. PubMed ID: 33995402
[TBL] [Abstract][Full Text] [Related]
10. Molecular targeting of islet autoantigens.
Stadinski B; Kappler J; Eisenbarth GS
Immunity; 2010 Apr; 32(4):446-56. PubMed ID: 20412755
[TBL] [Abstract][Full Text] [Related]
11. Human T-cell responses to islet cell antigens.
Sønderstrup G; Durinovich-Belló I
Curr Dir Autoimmun; 2001; 4():239-51. PubMed ID: 11569405
[No Abstract] [Full Text] [Related]
12. Islet cell antigens in the prediction and prevention of insulin-dependent diabetes mellitus.
Bonifacio E; Christie MR
Ann Med; 1997 Oct; 29(5):405-12. PubMed ID: 9453288
[TBL] [Abstract][Full Text] [Related]
13. CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes.
Sarikonda G; Pettus J; Phatak S; Sachithanantham S; Miller JF; Wesley JD; Cadag E; Chae J; Ganesan L; Mallios R; Edelman S; Peters B; von Herrath M
J Autoimmun; 2014 May; 50():77-82. PubMed ID: 24387802
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic islet cell antibodies (ICA): towards a molecular understanding of the autoantigens.
Scherbaum WA
Clin Endocrinol (Oxf); 1994 Jan; 40(1):15-8. PubMed ID: 7508344
[No Abstract] [Full Text] [Related]
15. Assay for islet cell antibodies with rat pancreas and peroxidase protein A.
Colman PG; Tautkus M; Rabizadeh A; Cahill C; Eisenbarth GS
Diabetes Care; 1988 Apr; 11(4):367-8. PubMed ID: 2841079
[No Abstract] [Full Text] [Related]
16. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
18. Type 1 diabetes mellitus as a polygenic multifactorial disease: immunopathogenic mechanisms of beta-cell destruction.
Dotta F; Fondelli C; Di Mario U
Acta Biomed; 2005; 76 Suppl 3():14-8. PubMed ID: 16915790
[No Abstract] [Full Text] [Related]
19. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.
Cooke A; Mandel TE
J Endocrinol Invest; 1994; 17(7):586-93. PubMed ID: 7829835
[No Abstract] [Full Text] [Related]
20. Pancreas Pathology During the Natural History of Type 1 Diabetes.
Rodriguez-Calvo T; Richardson SJ; Pugliese A
Curr Diab Rep; 2018 Oct; 18(11):124. PubMed ID: 30293191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
